Healthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study

BACKGROUND: Poor asthma control is associated with high short-acting β(2)-agonist (SABA) use. AIM: To assess asthma-related healthcare resource utilisation (HCRU) and medication costs associated with high versus low SABA prescriptions in the UK. DESIGN & SETTING: Analysis of SABINA I (SABA use I...

Descripción completa

Detalles Bibliográficos
Autores principales: Attar-Zadeh, Darush, Capstick, Toby, Leese, Deborah, Arnetorp, Sofie, Rapsomaniki, Eleni, Da Costa, Keith Peres, Maslova, Ekaterina, Xu, Yang, Gibson, Danny, Quint, Jennifer K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646192/
https://www.ncbi.nlm.nih.gov/pubmed/36759020
http://dx.doi.org/10.3399/BJGPO.2023.0015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646192/
https://www.ncbi.nlm.nih.gov/pubmed/36759020
http://dx.doi.org/10.3399/BJGPO.2023.0015

Ejemplares similares